Category: Acanya

  • Clascoterone Cream (Winlevi) for Acne

    Date:  December 27, 2021 Issue #:  1640 Summary:  The FDA has approved Winlevi (Sun), a 1% cream formulation of the androgen receptor inhibitor clascoterone, for treatment of acne vulgaris in patients ≥12 years old. It is the first topical androgen receptor inhibitor to be approved by the FDA.